Results 181 to 190 of about 67,431 (260)

Impact of China's National Volume-Based Procurement Policy on the Affordability and Utilization of Tyrosine Kinase Inhibitors for Childhood Leukemia. [PDF]

Health Data Sci
Li Y, Xie Y, Liu F, Wu Y, Liu S, Han X, Fan X, Yang Z, Jiang B.   +8 more
europepmc   +1 more source

Therapeutic Targets for Overcoming BCR::ABL1 Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid Leukemia. [PDF]

Oncol Res
Tsubaki M, Matsuo T, Komori R.
europepmc   +1 more source

Is Neoadjuvancy with Imatinib Useful Before Mohs Surgery in Locally Advanced Dermatofibrosarcoma Protuberans? Experience of a Dermato-Oncology Referral Center. [PDF]

Int J Mol Sci
Bota-Llorca A, Llombart-Cussac B, Serra-Guillén C, López-Guerrero JA, Traves V, Sanmartín-Martínez JJ, Requena C, Nagore E, Padilla-Esquivel J, Millán-Esteban D, Mayo F, Sanmartín O.   +11 more
europepmc   +1 more source

Langerhans Cell Histiocytosis Associated With Chronic Myeloid Leukemia: A Pediatric Case Report. [PDF]

Cancer Rep (Hoboken)
Latifi A, Yousefian S.
europepmc   +1 more source

B-Lymphoblastic Leukemia With Isolated Central Nervous System Relapse Mimicking a Vestibular Schwannoma. [PDF]

Clin Case Rep
Ng JY, Lalloo ST, Milliken S, Polizzotto MN.   +3 more
europepmc   +1 more source

Targeting STAT5A via CRISPR/Cas9 restores TKI sensitivity in resistant chronic myeloid leukemia cells. [PDF]

Med Oncol
Çelik B, Kiraz Y, Şahin Y, Tezcanlı Kaymaz B.   +3 more
europepmc   +1 more source

BCR::ABL1 tyrosine kinase inhibitors induce ribosome collisions to activate ZAK-dependent ribotoxic stress and apoptosis in chronic myeloid leukemia. [PDF]

Leukemia
Park J, Kim SH, Park J, Park H, Kim H, Kim DW, Lim C.   +6 more
europepmc   +1 more source

Imatinib and nilotinib are equally successful in achieving therapy-free remission. [PDF]

Blood Cancer J
Cheng F, Wang Y, Yang Y, Du X, Zhu Y, Weng J, Xu N, Huang J, Liu Z, Ren H, Zhao H, Zhu H, Jiang Q, Zhang Y, Li W.   +14 more
europepmc   +1 more source

When precision medicine meets human behavior: limits of artificial intelligence in predicting imatinib adherence. [PDF]

J Gastrointest Oncol
Kanda T.
europepmc   +1 more source

A CML Patient with Unintentional Bosutinib Exposure During the First Trimester of Pregnancy [PDF]

Turk J Haematol
Küçükbaş Özönder GN, Terzi Demirsoy E, Mehtap Ö, Metli K.   +3 more
europepmc   +1 more source